CVS Group Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
CVS Group wird ein jährliches Gewinn- und Umsatzwachstum von 15.5% bzw. 5.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 15.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.1% betragen.
Wichtige Informationen
15.5%
Wachstumsrate der Gewinne
15.8%
EPS-Wachstumsrate
Healthcare Gewinnwachstum | 23.3% |
Wachstumsrate der Einnahmen | 5.5% |
Zukünftige Eigenkapitalrendite | 15.1% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 20 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
CVS Group plc's (LON:CVSG) Price In Tune With Earnings
Oct 16Should You Think About Buying CVS Group plc (LON:CVSG) Now?
Sep 10CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
Jun 05CVS Group (LON:CVSG) Has A Pretty Healthy Balance Sheet
Mar 28CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
Feb 29Getting In Cheap On CVS Group plc (LON:CVSG) Is Unlikely
Feb 09Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Dec 11Most Shareholders Will Probably Agree With CVS Group plc's (LON:CVSG) CEO Compensation
Nov 23Is CVS Group (LON:CVSG) A Risky Investment?
Nov 15CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 89% Above Its Share Price
Oct 27Here's Why CVS Group (LON:CVSG) Has Caught The Eye Of Investors
Sep 23CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
Sep 08We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Jun 28Should You Investigate CVS Group plc (LON:CVSG) At UK£20.72?
May 25A Look At The Fair Value Of CVS Group plc (LON:CVSG)
May 12Should You Be Adding CVS Group (LON:CVSG) To Your Watchlist Today?
Apr 15A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Feb 01Here's Why We Think CVS Group (LON:CVSG) Might Deserve Your Attention Today
Jan 05Returns At CVS Group (LON:CVSG) Are On The Way Up
Nov 30CVS Group plc's (LON:CVSG) CEO Looks Like They Deserve Their Pay Packet
Nov 17CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 41% Above Its Share Price
Oct 26Does CVS Group (LON:CVSG) Have A Healthy Balance Sheet?
Sep 29Is Now The Time To Put CVS Group (LON:CVSG) On Your Watchlist?
Sep 17At UK£16.41, Is It Time To Put CVS Group plc (LON:CVSG) On Your Watch List?
Sep 02CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
Aug 04Here's Why We Think CVS Group (LON:CVSG) Is Well Worth Watching
Jun 14Should You Investigate CVS Group plc (LON:CVSG) At UK£17.94?
Jun 01CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
May 05Is CVS Group (LON:CVSG) A Risky Investment?
Apr 23Is There An Opportunity With CVS Group plc's (LON:CVSG) 37% Undervaluation?
Apr 09When Should You Buy CVS Group plc (LON:CVSG)?
Feb 19A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Nov 23Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Oct 25Here's Why We Think CVS Group (LON:CVSG) Is Well Worth Watching
Oct 12We Think CVS Group (LON:CVSG) Can Manage Its Debt With Ease
Sep 26CVS Group (LON:CVSG) Has Some Way To Go To Become A Multi-Bagger
Aug 27A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Aug 05Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Jun 16Return Trends At CVS Group (LON:CVSG) Aren't Appealing
May 16Estimating The Fair Value Of CVS Group plc (LON:CVSG)
May 01We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Apr 16Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
6/30/2027 | 771 | 58 | 68 | 112 | 7 |
6/30/2026 | 732 | 53 | 60 | 105 | 9 |
6/30/2025 | 696 | 43 | 48 | 99 | 9 |
6/30/2024 | 647 | 26 | 25 | 68 | N/A |
12/31/2023 | 642 | 35 | 46 | 89 | N/A |
9/30/2023 | 625 | 39 | 42 | 87 | N/A |
6/30/2023 | 589 | 48 | 39 | 85 | N/A |
3/31/2023 | 593 | 36 | 43 | 83 | N/A |
12/31/2022 | 577 | 29 | 48 | 81 | N/A |
9/30/2022 | 566 | 28 | 49 | 78 | N/A |
6/30/2022 | 554 | 26 | 51 | 76 | N/A |
3/31/2022 | 546 | 26 | 39 | 61 | N/A |
12/31/2021 | 538 | 26 | 26 | 47 | N/A |
9/30/2021 | 524 | 22 | 35 | 54 | N/A |
6/30/2021 | 510 | 19 | 44 | 60 | N/A |
3/31/2021 | 480 | 15 | 62 | 76 | N/A |
12/31/2020 | 449 | 11 | 80 | 92 | N/A |
9/30/2020 | 438 | 9 | 73 | 85 | N/A |
6/30/2020 | 428 | 6 | 65 | 78 | N/A |
3/31/2020 | 432 | 9 | 53 | 66 | N/A |
12/31/2019 | 436 | 13 | 41 | 55 | N/A |
9/30/2019 | 421 | 11 | 35 | 48 | N/A |
6/30/2019 | 407 | 8 | 29 | 41 | N/A |
3/31/2019 | 386 | 7 | 24 | 36 | N/A |
12/31/2018 | 365 | 7 | 19 | 31 | N/A |
9/30/2018 | 346 | 9 | 23 | 34 | N/A |
6/30/2018 | 327 | 11 | 27 | 37 | N/A |
3/31/2018 | 314 | 10 | N/A | 37 | N/A |
12/31/2017 | 300 | 10 | N/A | 36 | N/A |
9/30/2017 | 286 | 11 | N/A | 33 | N/A |
6/30/2017 | 272 | 12 | N/A | 30 | N/A |
3/31/2017 | 259 | 11 | N/A | N/A | N/A |
12/31/2016 | 247 | 10 | N/A | 29 | N/A |
9/30/2016 | 232 | 8 | N/A | 28 | N/A |
6/30/2016 | 218 | 7 | N/A | 28 | N/A |
3/31/2016 | 202 | 7 | N/A | N/A | N/A |
12/31/2015 | 186 | 6 | N/A | 22 | N/A |
9/30/2015 | 177 | 6 | N/A | 20 | N/A |
6/30/2015 | 167 | 7 | N/A | 19 | N/A |
3/31/2015 | 162 | 7 | N/A | 19 | N/A |
12/31/2014 | 156 | 6 | N/A | 20 | N/A |
9/30/2014 | 149 | 6 | N/A | 18 | N/A |
6/30/2014 | 143 | 5 | N/A | 17 | N/A |
3/31/2014 | 137 | 5 | N/A | 17 | N/A |
12/31/2013 | 131 | 5 | N/A | 16 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CVSGDas prognostizierte Gewinnwachstum (15.5% pro Jahr) liegt über der Sparquote (2.1%).
Ertrag vs. Markt: CVSGDie Erträge des Unternehmens (15.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (14.6% pro Jahr).
Hohe Wachstumserträge: CVSGDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CVSGDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.6% pro Jahr).
Hohe Wachstumseinnahmen: CVSGDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CVSGDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.1%).